Calithera Biosciences Inc (CALA)
0.0250
-0.01
(-37.38%)
USD |
OTCM |
Apr 18, 15:03
Calithera Biosciences Cash from Investing (Quarterly): -0.023M for Dec. 31, 2022
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -0.023M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.11M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.039M |
| September 30, 2021 | -0.108M |
| June 30, 2021 | 1.50M |
| March 31, 2021 | 6.50M |
| December 31, 2020 | 9.065M |
| September 30, 2020 | 21.99M |
| June 30, 2020 | 58.52M |
| March 31, 2020 | -0.614M |
| December 31, 2019 | 15.15M |
| September 30, 2019 | -35.21M |
| June 30, 2019 | 0.274M |
| March 31, 2019 | 8.996M |
| December 31, 2018 | -4.595M |
| September 30, 2018 | 16.14M |
| Date | Value |
|---|---|
| June 30, 2018 | 20.09M |
| March 31, 2018 | 21.17M |
| December 31, 2017 | 18.66M |
| September 30, 2017 | -7.504M |
| June 30, 2017 | -32.62M |
| March 31, 2017 | -76.96M |
| December 31, 2016 | 3.213M |
| September 30, 2016 | 8.193M |
| June 30, 2016 | 2.875M |
| March 31, 2016 | 9.424M |
| December 31, 2015 | 7.288M |
| September 30, 2015 | 3.242M |
| June 30, 2015 | -56.84M |
| March 31, 2015 | -20.47M |
| December 31, 2014 | -0.07M |
| September 30, 2014 | -0.304M |
| June 30, 2014 | -0.052M |
| March 31, 2014 | -0.06M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.21M
Minimum
Sep 2019
58.52M
Maximum
Jun 2020
5.127M
Average
--
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Ampio Pharmaceuticals Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.598M |
| Cash from Financing (Quarterly) | 0.004M |